Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 329 entries
Sorted by: Best Match Show Resources per page
Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease.

Endocrine connections

Ambrogio AG, Andrioli M, De Martin M, Cavagnini F, Pecori Giraldi F.
PMID: 29018154
Endocr Connect. 2017 Nov;6(8):791-799. doi: 10.1530/EC-17-0292. Epub 2017 Oct 10.

Recurrence of Cushing's disease after successful transsphenoidal surgery occurs in some 30% of the patients and the response to desmopressin shortly after surgery has been proposed as a marker for disease recurrence. The aim of the present study was...

Cite
Ambrogio AG, Andrioli M, De Martin M, et al. Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease. Endocr Connect. 2017;6(8):791-799doi: 10.1530/EC-17-0292.
Ambrogio, A. G., Andrioli, M., De Martin, M., Cavagnini, F., & Pecori Giraldi, F. (2017). Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease. Endocrine connections, 6(8), 791-799. https://doi.org/10.1530/EC-17-0292
Ambrogio, Alberto Giacinto, et al. "Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease." Endocrine connections vol. 6,8 (2017): 791-799. doi: https://doi.org/10.1530/EC-17-0292
Ambrogio AG, Andrioli M, De Martin M, Cavagnini F, Pecori Giraldi F. Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease. Endocr Connect. 2017 Nov;6(8):791-799. doi: 10.1530/EC-17-0292. Epub 2017 Oct 10. PMID: 29018154; PMCID: PMC5682421.
Copy Download .nbib Format: NLM
Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in .

Frontiers in aging neuroscience

Colini Baldeschi A, Pittaluga E, Andreola F, Rossi S, Cozzolino M, Nicotera G, Sferrazza G, Pierimarchi P, Serafino A.
PMID: 29449807
Front Aging Neurosci. 2018 Feb 01;10:20. doi: 10.3389/fnagi.2018.00020. eCollection 2018.

In the last decades increasing evidence indicated a crucial role of the Wnt/β-catenin signaling in development of midbrain dopaminergic (mDA) neurons. Recently dysregulation of this pathway has been proposed as a novel pathomechanism leading to Parkinson's disease (PD) and...

Cite
Colini Baldeschi A, Pittaluga E, Andreola F, et al. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in . Front Aging Neurosci. 2018;10:20doi: 10.3389/fnagi.2018.00020.
Colini Baldeschi, A., Pittaluga, E., Andreola, F., Rossi, S., Cozzolino, M., Nicotera, G., Sferrazza, G., Pierimarchi, P., & Serafino, A. (2018). Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in . Frontiers in aging neuroscience, 1020. https://doi.org/10.3389/fnagi.2018.00020
Colini Baldeschi, Arianna, et al. "Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in ." Frontiers in aging neuroscience vol. 10 (2018): 20. doi: https://doi.org/10.3389/fnagi.2018.00020
Colini Baldeschi A, Pittaluga E, Andreola F, Rossi S, Cozzolino M, Nicotera G, Sferrazza G, Pierimarchi P, Serafino A. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in . Front Aging Neurosci. 2018 Feb 01;10:20. doi: 10.3389/fnagi.2018.00020. eCollection 2018. PMID: 29449807; PMCID: PMC5799264.
Copy Download .nbib Format: NLM
Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes.

Computational and structural biotechnology journal

Andreoli F, Del Rio A.
PMID: 26082827
Comput Struct Biotechnol J. 2015 May 07;13:358-65. doi: 10.1016/j.csbj.2015.04.007. eCollection 2015.

Growing evidences show that epigenetic mechanisms play crucial roles in the genesis and progression of many physiopathological processes. As a result, research in epigenetic grew at a fast pace in the last decade. In particular, the study of histone...

Cite
Andreoli F, Del Rio A. Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes. Comput Struct Biotechnol J. 2015;13:358-65doi: 10.1016/j.csbj.2015.04.007.
Andreoli, F., & Del Rio, A. (2015). Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes. Computational and structural biotechnology journal, 13358-65. https://doi.org/10.1016/j.csbj.2015.04.007
Andreoli, Federico, and Del Rio, Alberto. "Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes." Computational and structural biotechnology journal vol. 13 (2015): 358-65. doi: https://doi.org/10.1016/j.csbj.2015.04.007
Andreoli F, Del Rio A. Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes. Comput Struct Biotechnol J. 2015 May 07;13:358-65. doi: 10.1016/j.csbj.2015.04.007. eCollection 2015. PMID: 26082827; PMCID: PMC4459771.
Copy Download .nbib Format: NLM
Effect of Hatha Yoga on Anxiety: A Meta-Analysis.

Journal of evidence-based medicine

Hofmann SG, Andreoli G, Carpenter JK, Curtiss J.
PMID: 27203378
J Evid Based Med. 2016 Aug;9(3):116-124. doi: 10.1111/jebm.12204. Epub 2016 May 20.

OBJECTIVE: Some evidence suggests that Hatha yoga might be an effective practice to reduce anxiety. To examine the effect of Hatha yoga on anxiety, we conducted a meta-analysis of relevant studies extracted from PubMed, PsycINFO, the Cochrane Library, and...

Cite
Hofmann SG, Andreoli G, Carpenter JK, et al. Effect of Hatha Yoga on Anxiety: A Meta-Analysis. J Evid Based Med. 2016;9(3):116-124doi: 10.1111/jebm.12204.
Hofmann, S. G., Andreoli, G., Carpenter, J. K., & Curtiss, J. (2016). Effect of Hatha Yoga on Anxiety: A Meta-Analysis. Journal of evidence-based medicine, 9(3), 116-124. https://doi.org/10.1111/jebm.12204
Hofmann, Stefan G, et al. "Effect of Hatha Yoga on Anxiety: A Meta-Analysis." Journal of evidence-based medicine vol. 9,3 (2016): 116-124. doi: https://doi.org/10.1111/jebm.12204
Hofmann SG, Andreoli G, Carpenter JK, Curtiss J. Effect of Hatha Yoga on Anxiety: A Meta-Analysis. J Evid Based Med. 2016 Aug;9(3):116-124. doi: 10.1111/jebm.12204. Epub 2016 May 20. PMID: 27203378; PMCID: PMC5116432.
Copy Download .nbib Format: NLM
Fascial Manipulation® for chronic aspecific low back pain: a single blinded randomized controlled trial.

F1000Research

Branchini M, Lopopolo F, Andreoli E, Loreti I, Marchand AM, Stecco A.
PMID: 26834998
F1000Res. 2015 Nov 03;4:1208. doi: 10.12688/f1000research.6890.1. eCollection 2015.

BACKGROUND: The therapeutic approach to chronic aspecific low back pain (CALBP) has to consider the multifactorial aetiology of the disorder. International guidelines do not agree on unequivocal treatment indications. Recommendations for fascial therapy are few and of low level...

Cite
Branchini M, Lopopolo F, Andreoli E, et al. Fascial Manipulation® for chronic aspecific low back pain: a single blinded randomized controlled trial. F1000Res. 2015;4:1208doi: 10.12688/f1000research.6890.1.
Branchini, M., Lopopolo, F., Andreoli, E., Loreti, I., Marchand, A. M., & Stecco, A. (2015). Fascial Manipulation® for chronic aspecific low back pain: a single blinded randomized controlled trial. F1000Research, 41208. https://doi.org/10.12688/f1000research.6890.1
Branchini, Mirco, et al. "Fascial Manipulation® for chronic aspecific low back pain: a single blinded randomized controlled trial." F1000Research vol. 4 (2015): 1208. doi: https://doi.org/10.12688/f1000research.6890.1
Branchini M, Lopopolo F, Andreoli E, Loreti I, Marchand AM, Stecco A. Fascial Manipulation® for chronic aspecific low back pain: a single blinded randomized controlled trial. F1000Res. 2015 Nov 03;4:1208. doi: 10.12688/f1000research.6890.1. eCollection 2015. PMID: 26834998; PMCID: PMC4706049.
Copy Download .nbib Format: NLM
Inferior Vena Cava Filter-Related Thrombus/Deep Vein Thrombosis: Data and Management.

Seminars in interventional radiology

Andreoli JM, Thornburg BG, Hickey RM.
PMID: 27247478
Semin Intervent Radiol. 2016 Jun;33(2):101-4. doi: 10.1055/s-0036-1581087.

Recurrent deep venous thrombosis and inferior vena cava (IVC) thrombosis are well-described complications following IVC filter placement. IVC thrombosis ranges in severity of clinical presentation, but can lead to significant morbidity and mortality with incidence rates depending on patient...

Cite
Andreoli JM, Thornburg BG, Hickey RM. Inferior Vena Cava Filter-Related Thrombus/Deep Vein Thrombosis: Data and Management. Semin Intervent Radiol. 2016;33(2):101-4doi: 10.1055/s-0036-1581087.
Andreoli, J. M., Thornburg, B. G., & Hickey, R. M. (2016). Inferior Vena Cava Filter-Related Thrombus/Deep Vein Thrombosis: Data and Management. Seminars in interventional radiology, 33(2), 101-4. https://doi.org/10.1055/s-0036-1581087
Andreoli, Jessica M, et al. "Inferior Vena Cava Filter-Related Thrombus/Deep Vein Thrombosis: Data and Management." Seminars in interventional radiology vol. 33,2 (2016): 101-4. doi: https://doi.org/10.1055/s-0036-1581087
Andreoli JM, Thornburg BG, Hickey RM. Inferior Vena Cava Filter-Related Thrombus/Deep Vein Thrombosis: Data and Management. Semin Intervent Radiol. 2016 Jun;33(2):101-4. doi: 10.1055/s-0036-1581087. PMID: 27247478; PMCID: PMC4862844.
Copy Download .nbib Format: NLM
S10.Emergency psychiatry and borderline disorders.

European psychiatry : the journal of the Association of European Psychiatrists

De Clercq M, Andreoli A, Pardoen D, Furlan PM.
PMID: 11861144
Eur Psychiatry. 2000 Jun;15(1):65-68. doi: 10.1016/s0924-9338(00)00258-3.

No abstract available.

Cite
De Clercq M, Andreoli A, Pardoen D, et al. S10.Emergency psychiatry and borderline disorders. Eur Psychiatry. 2000;15(1):65-68doi: 10.1016/s0924-9338(00)00258-3.
De Clercq, M., Andreoli, A., Pardoen, D., & Furlan, P. M. (2000). S10.Emergency psychiatry and borderline disorders. European psychiatry : the journal of the Association of European Psychiatrists, 15(1), 65-68. https://doi.org/10.1016/s0924-9338(00)00258-3
De Clercq, M, et al. "S10.Emergency psychiatry and borderline disorders." European psychiatry : the journal of the Association of European Psychiatrists vol. 15,1 (2000): 65-68. doi: https://doi.org/10.1016/s0924-9338(00)00258-3
De Clercq M, Andreoli A, Pardoen D, Furlan PM. S10.Emergency psychiatry and borderline disorders. Eur Psychiatry. 2000 Jun;15(1):65-68. doi: 10.1016/s0924-9338(00)00258-3. PMID: 11861144.
Copy Download .nbib Format: NLM
Temperature measurements of fusion plasmas produced by Petawatt-Laser-Irradiated D2 - (3)He or CD4 - (3)He clustering gases.

Physical review letters

Bang W, Barbui M, Bonasera A, Dyer G, Quevedo HJ, Hagel K, Schmidt K, Consoli F, De Angelis R, Andreoli P, Gaul E, Bernstein AC, Donovan M, Barbarino M, Kimura S, Mazzocco M, Sura J, Natowitz JB, Ditmire T.
PMID: 23952411
Phys Rev Lett. 2013 Aug 02;111(5):055002. doi: 10.1103/PhysRevLett.111.055002. Epub 2013 Jul 30.

Two different methods have been employed to determine the plasma temperature in a laser-cluster fusion experiment on the Texas Petawatt laser. In the first, the temperature was derived from time-of-flight data of deuterium ions ejected from exploding D(2) or...

Cite
Bang W, Barbui M, Bonasera A, et al. Temperature measurements of fusion plasmas produced by Petawatt-Laser-Irradiated D2 - (3)He or CD4 - (3)He clustering gases. Phys Rev Lett. 2013;111(5):055002doi: 10.1103/PhysRevLett.111.055002.
Bang, W., Barbui, M., Bonasera, A., Dyer, G., Quevedo, H. J., Hagel, K., Schmidt, K., Consoli, F., De Angelis, R., Andreoli, P., Gaul, E., Bernstein, A. C., Donovan, M., Barbarino, M., Kimura, S., Mazzocco, M., Sura, J., Natowitz, J. B., & Ditmire, T. (2013). Temperature measurements of fusion plasmas produced by Petawatt-Laser-Irradiated D2 - (3)He or CD4 - (3)He clustering gases. Physical review letters, 111(5), 055002. https://doi.org/10.1103/PhysRevLett.111.055002
Bang, W, et al. "Temperature measurements of fusion plasmas produced by Petawatt-Laser-Irradiated D2 - (3)He or CD4 - (3)He clustering gases." Physical review letters vol. 111,5 (2013): 055002. doi: https://doi.org/10.1103/PhysRevLett.111.055002
Bang W, Barbui M, Bonasera A, Dyer G, Quevedo HJ, Hagel K, Schmidt K, Consoli F, De Angelis R, Andreoli P, Gaul E, Bernstein AC, Donovan M, Barbarino M, Kimura S, Mazzocco M, Sura J, Natowitz JB, Ditmire T. Temperature measurements of fusion plasmas produced by Petawatt-Laser-Irradiated D2 - (3)He or CD4 - (3)He clustering gases. Phys Rev Lett. 2013 Aug 02;111(5):055002. doi: 10.1103/PhysRevLett.111.055002. Epub 2013 Jul 30. PMID: 23952411.
Copy Download .nbib Format: NLM
Prevalence and clinical feature of the "overlap syndrome", obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population.

Sleep & breathing = Schlaf & Atmung

Rizzi M, Palma P, Andreoli A, Greco M, Bamberga M, Antivalle M, Sergi M.
PMID: 19404699
Sleep Breath. 1997 Sep;2(3):68-72. doi: 10.1007/BF03038868.

PURPOSE: The association of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), defined overlap syndrome by Flenley, is frequent. Aims of the present study were to assess the frequency of overlap syndrome in 168 consecutive OSA patients,...

Cite
Rizzi M, Palma P, Andreoli A, et al. Prevalence and clinical feature of the "overlap syndrome", obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population. Sleep Breath. 1997;2(3):68-72doi: 10.1007/BF03038868.
Rizzi, M., Palma, P., Andreoli, A., Greco, M., Bamberga, M., Antivalle, M., & Sergi, M. (1997). Prevalence and clinical feature of the "overlap syndrome", obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population. Sleep & breathing = Schlaf & Atmung, 2(3), 68-72. https://doi.org/10.1007/BF03038868
Rizzi, M, et al. "Prevalence and clinical feature of the "overlap syndrome", obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population." Sleep & breathing = Schlaf & Atmung vol. 2,3 (1997): 68-72. doi: https://doi.org/10.1007/BF03038868
Rizzi M, Palma P, Andreoli A, Greco M, Bamberga M, Antivalle M, Sergi M. Prevalence and clinical feature of the "overlap syndrome", obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population. Sleep Breath. 1997 Sep;2(3):68-72. doi: 10.1007/BF03038868. PMID: 19404699.
Copy Download .nbib Format: NLM
Application of the EU-SILC 2011 data module "intergenerational transmission of disadvantage" to robust analysis of inequality of opportunity.

Data in brief

Andreoli F, Fusco A.
PMID: 31406909
Data Brief. 2019 Jul 23;25:104301. doi: 10.1016/j.dib.2019.104301. eCollection 2019 Aug.

This data article describes the original data, the sample selection process and the variables used in Andreoli and Fusco (Andreoli and Fusco, 2019) to estimate gap curves for a sample of European countries. Raw data are from 2011 roaster...

Cite
Andreoli F, Fusco A. Application of the EU-SILC 2011 data module "intergenerational transmission of disadvantage" to robust analysis of inequality of opportunity. Data Brief. 2019;25:104301doi: 10.1016/j.dib.2019.104301.
Andreoli, F., & Fusco, A. (2019). Application of the EU-SILC 2011 data module "intergenerational transmission of disadvantage" to robust analysis of inequality of opportunity. Data in brief, 25104301. https://doi.org/10.1016/j.dib.2019.104301
Andreoli, Francesco, and Fusco, Alessio. "Application of the EU-SILC 2011 data module "intergenerational transmission of disadvantage" to robust analysis of inequality of opportunity." Data in brief vol. 25 (2019): 104301. doi: https://doi.org/10.1016/j.dib.2019.104301
Andreoli F, Fusco A. Application of the EU-SILC 2011 data module "intergenerational transmission of disadvantage" to robust analysis of inequality of opportunity. Data Brief. 2019 Jul 23;25:104301. doi: 10.1016/j.dib.2019.104301. eCollection 2019 Aug. PMID: 31406909; PMCID: PMC6685694.
Copy Download .nbib Format: NLM
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.

Auto- immunity highlights

Nalli C, Somma V, Andreoli L, Büttner T, Schierack P, Mahler M, Roggenbuck D, Tincani A.
PMID: 29845583
Auto Immun Highlights. 2018 May 29;9(1):6. doi: 10.1007/s13317-018-0106-0.

PURPOSE: Anti-phospholipid antibodies (aPL) analyzed by line immunoassay (LIA) can recognize betaMETHODS: Thirty-four APS patients (14 arterial/venous thrombosis, 16 pregnancy morbidity, and 4 both), 41 patients with SARD lacking clinical APS criteria but demonstrating positivity for anti-βRESULTS: Comparison of...

Cite
Nalli C, Somma V, Andreoli L, et al. Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto Immun Highlights. 2018;9(1):6doi: 10.1007/s13317-018-0106-0.
Nalli, C., Somma, V., Andreoli, L., Büttner, T., Schierack, P., Mahler, M., Roggenbuck, D., & Tincani, A. (2018). Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto- immunity highlights, 9(1), 6. https://doi.org/10.1007/s13317-018-0106-0
Nalli, Cecilia, et al. "Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases." Auto- immunity highlights vol. 9,1 (2018): 6. doi: https://doi.org/10.1007/s13317-018-0106-0
Nalli C, Somma V, Andreoli L, Büttner T, Schierack P, Mahler M, Roggenbuck D, Tincani A. Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto Immun Highlights. 2018 May 29;9(1):6. doi: 10.1007/s13317-018-0106-0. PMID: 29845583; PMCID: PMC5975024.
Copy Download .nbib Format: NLM
Easily Regenerated Readily Deployable Absorbent for Heavy Metal Removal from Contaminated Water.

Scientific reports

Alagappan PN, Heimann J, Morrow L, Andreoli E, Barron AR.
PMID: 28751753
Sci Rep. 2017 Jul 27;7(1):6682. doi: 10.1038/s41598-017-06734-7.

Although clean and abundant water is the keystone of thriving communities, increasing demand and volatile climate patterns are depleting rivers and aquifers. Moreover, the quality of such water sources is threatened by noxious contaminants, of which heavy metals represents...

Cite
Alagappan PN, Heimann J, Morrow L, et al. Easily Regenerated Readily Deployable Absorbent for Heavy Metal Removal from Contaminated Water. Sci Rep. 2017;7(1):6682doi: 10.1038/s41598-017-06734-7.
Alagappan, P. N., Heimann, J., Morrow, L., Andreoli, E., & Barron, A. R. (2017). Easily Regenerated Readily Deployable Absorbent for Heavy Metal Removal from Contaminated Water. Scientific reports, 7(1), 6682. https://doi.org/10.1038/s41598-017-06734-7
Alagappan, Perry N, et al. "Easily Regenerated Readily Deployable Absorbent for Heavy Metal Removal from Contaminated Water." Scientific reports vol. 7,1 (2017): 6682. doi: https://doi.org/10.1038/s41598-017-06734-7
Alagappan PN, Heimann J, Morrow L, Andreoli E, Barron AR. Easily Regenerated Readily Deployable Absorbent for Heavy Metal Removal from Contaminated Water. Sci Rep. 2017 Jul 27;7(1):6682. doi: 10.1038/s41598-017-06734-7. PMID: 28751753; PMCID: PMC5532212.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 329 entries